For profit Phase 3
Founded: Glostrup Denmark (1996)
Status: Acquired by Agilent Technologies, Inc. (2012)

Organization Overview

First Clinical Trial
2008
NCT00689156
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree